RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO ... of BIO in relation to earlier this year. Last month, Andrew Last, the EVP & COO of BIO sold 3,000. ...

BIO-RAD LABORATORIES ($BIO) posted quarterly earnings results on Thursday, February 13th. The company reported earnings of $2.90 per share, beating estimates of $2.90 ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long term Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders know that all too ...

HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO) reported fourth-quarter results that fell short of analyst expectations, sending shares down 4% in after-hours trading Thursday. The life ...

A month has gone by since the last earnings report for Bio-Rad Laboratories (BIO). Shares have lost about 5.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

We have seen $5,231,647 of award payments to $BIO over the last year. Here are some of the awards which we have have seen pay out the most over the last year: Wall ...

October 30, 2024 Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit Diagnostics firm Bio-Rad Laboratories posted third-quarter profit above Wall Street ...

Based on Bio-Rad Laboratories’ latest earnings release ... Most recently, in September 2024, Andrew Last, the EVP & COO of BIO sold 3,000.00 shares for a total of $989,790.00.